The new Bengaluru-based platform integrates mass spectrometry-driven workflows with advanced bioanalytical and clinical research capabilities to deliver regulatory‑ready data for global biopharma sponsors. Bengaluru, India — Agilent Technologies, a global leader in analytical and laboratory solutions, today announced a strategic collaboration with Veeda Lifesciences to strengthen regulatory‑aligned analytical and bioanalytical workflows supporting biopharma development, as […]
Werfen, global leader in specialized diagnostics, has announced a strategic collaboration with Oxford Nanopore Technologies to validate Werfen’s specialized transplant assay portfolios for use on Oxford Nanopore’s sequencing platforms. The collaboration combines Werfen’s validated transplant assays with Oxford Nanopore’s sequencing technology to deliver fast, high-resolution results, essential for precise donor-recipient matching. It also streamlines and […]
Agreement strengthens Aurigene’s discovery platforms with access to foundational CRISPR/Cas9 intellectual property, enabling responsible innovation and enhanced global partner support DUBLIN and BANGALORE, India — ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced that it has signed a non-exclusive license agreement with Aurigene Pharmaceutical Services Limited (“Aurigene Services”), an end-to-end integrated global CRDMO […]
UK-based gene therapy CDMO embeds NanoMosaic’s Tessie platform across its AAV development and manufacturing services. STEVENAGE, England & WALTHAM, Mass. — Trisk Bio Ltd, a UK-based AAV contract development and manufacturing organisation (CDMO), and NanoMosaic, Inc., a leader in advanced analytical technologies for cell and gene therapy, today announced a partnership to embed the Tessie […]
Genovis AB and MGI Tech Co., Ltd. today announce a strengthened collaboration to advance RNA sequencing solutions. The companies have expanded their commercial agreement to integrate Genovis’ SEQURNA reagents with MGI Tech’s high-performance sequencing platforms, enabling researchers to benefit from enhanced RNA preservation and improved sequencing performance. The partnership marks an important step for both […]
DÜSSELDORF, Germany — LenioBio GmbH, a TechBio company commercializing its ALiCE® cell-free protein expression platform, today announced a collaborative agreement with Twist Bioscience Corporation. The collaboration will integrate our ALiCE® platform with Twist’s DNA manufacturing and automation capabilities to accelerate the design–build–test cycle for protein expression services—delivering experimental results back to customers’ and partners’ AI […]
Toronto companies partner to provide an integrated platform that runs the complete clinical genetics workflow, from patient intake to diagnostic report, entirely on Canadian infrastructure. TORONTO, Ontario — DNAstack and PhenoTips today announced an integrated platform that runs clinical genetics workflows, from patient intake and phenotyping to genomic interpretation and diagnostic report, entirely on Canadian infrastructure. At a time […]
Licensed purification methods address a key challenge in producing high‑purity, 100+nt RNA constructs used in CRISPR and functional genomics Boulder, CO – Cirena Inc. licensed a validated long RNA purification technology from Agilent Technologies, Inc. as it looks to expand access to high purity RNA constructs used in genome editing and functional genomics research. The […]
Licensed purification methods address a key challenge in producing high‑purity, 100+nt RNA constructs used in CRISPR and functional genomics Boulder, CO – Cirena Inc. licensed a validated long RNA purification technology from Agilent Technologies, Inc. as it looks to expand access to high purity RNA constructs used in genome editing and functional genomics research. The […]
Combines validated scientific engines with accelerated computing and AI to enable more scalable, integrated modeling workflows across the drug development lifecycle RESEARCH TRIANGLE PARK, N.C. — Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the launch of a […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
